Arvind Remedies (Delisted) share news and announcements

BSE: 531823

Last traded ₹4.65 on 13 Jun 2016

Delisted on 4 Jul 2018.

Arvind Remedies board meetings

89 filed, newest first. Page 1 of 2.

  1. Aug 2016

  2. Mar 2016

    • 22 Mar · Board meeting

      Board of Directors of the Company at its meeting held on March 21, 2016, has taken the following decision: - Board approved the notice ....
  3. Feb 2016

  4. Dec 2015

    • 10 Dec · Board meeting

      Board of Directors of the Company at its meeting held on December 10, 2015, has taken the following decisions: 1. It was noted that ....
  5. Nov 2015

  6. Jul 2015

  7. May 2015

  8. Feb 2015

  9. Nov 2014

    • 13 Nov · Board meeting

      Mr. R. Rajamohan, Director has resigned from the Company with effect from November 05, 2014. This was considered in the Board meeting of the Company ....
  10. Oct 2014

    • 31 Oct · Board meeting

      To consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2014 along with the Limited Review Report.
  11. Aug 2014

  12. Jul 2014

    • 14 Jul · Board meeting

      To consider and approve the unaudited financial results for the quarter ended June 30, 2014 along with the Limited Review report of audit, the notice of the 26th Annual General Meeting of the Company and to fix the Book Closure for the purpose of AGM and for payment of dividend.
  13. May 2014

  14. Apr 2014

  15. Jan 2014

    • 21 Jan · Board meeting

      To consider and approve the unaudited financial results of the Company for the quarter ended December 31, 2013.
  16. Oct 2013

    • 17 Oct · Board meeting

      To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2013
  17. Sep 2013

  18. Aug 2013

    • 16 Aug · Board meeting

      Mr. K. V. Narayan Director has resigned from the Company with effect from July 23, 2013 and the same has been considered and accepted by the Board ....
  19. Jul 2013

    • 16 Jul · Board meeting

      To consider and approve the unaudited financial results for the quarter ended June 30, 2013.
  20. May 2013

    • 16 May · Board meeting

      Board of Directors of the Company at its meeting held on May 15, 2013 has taken the following decisions : (1). Board approved the Demerger of Irungattukottai Unit of the Company into their Wholly Owned Subsidiary (WOS), Arvind Wellness Limited and fixed the appointed date as April 08, 2013. It was noted that the resultant Company (WOS) will be issuing preference share to the shareholders of ARL as a part of the demerger scheme. For the above purpose, the Board authorised Dr. B. Arvind Shah, Managing Director to sign, execute and file necessary applications/ documents/ papers in matters relating to Demerger to various Statutory Authorities including Stock Exchange, High Court etc.
    • 10 May · Board meeting

      To consider and take on record the Consolidated audited financial results of the company for the quarter ended March 31, 2013 and the Audit report thereon.
  21. Feb 2013

    • 16 Feb · Board meeting

      Board of Directors of the Company at its meeting held on February 12, 2013, has appointed Mr. V. Santhanaraman as Additional Director of the ....
    • 12 Feb · Board meeting

      Board of Directors of the Company at its meeting held on February 12, 2013, inter alia, has considered and in principally approved for demerger ....
  22. Jan 2013

    • 23 Jan · Board meeting

      To consider and take on record the unaudited financial results of the Company for the quarter ended December 31, 2012 and the Limited Review Audit report thereon.
    • 16 Jan · Board meeting

      To consider and approve allotment of 1,98,96,000 equity warrants of Rs.25. each.
  23. Nov 2012

    • 19 Nov · Board meeting

      In the Board meeting held on November 08, 2012 the Board has discussed and decided that the Company has plans to get registered its Irungatukottai unit as USFDA project. Company has received offer from M/s. Vensun Pharmaceuticals LLc in US for marketing tie up and for development of products with USFDA registration in the new plant at Irungatukottai, Dist. Kancheepuram Tamil Nadu and for supply to that country. Board authorized Managing Director to sign the MOU with the said company and to finalise the terms and conditions in this regard.
    • 5 Nov · Board meeting

      Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on November 09, 2012 to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2012 along with the limited review report of audit. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled, preponing it to November 08, 2012 considering the convenience of directors.

      Not held on this date

  24. Oct 2012

    • 31 Oct · Board meeting

      To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2012 along with the limited review report of audit.
  25. Jul 2012

    • 16 Jul · Board meeting

      To consider and approve the unaudited financial results for the quarter ended June 30, 2012 along with the limited review report of auditors.
  26. May 2012

    • 14 May · Board meeting

      To consider and take on record the audited financial results of the company for the quarter and year ended March 31, 2012 and to recommend dividend if any, on the equity shares of the Company.
  27. Apr 2012

    • 30 Apr · Board meeting

      Board of Directors of the Company at its meeting held on April 28, 2012, inter alia, has approved the appointment of following persons as Executive ....
    • 23 Apr · Board meeting

      Meeting of Board of Directors of the Company is convened on April 28, 2012 immediately after the Extra Ordinary General Meeting, to decide the record date.
  28. Feb 2012